June 30, 2021
12:00 pm – 1:00 pm
Speaker: Josh Stevens, President and CCO, DayTwo
Ten years ago, two scientists had a hypothesis that the body’s glycemic response to food was personalized and due to not just food, but the person eating the food. To prove their hypothesis they conducted the largest nutrition trials ever conducted and demonstrated that the gut microbiome has meaningful predictive value of an individuals personalized response to food. Ten years later, DayTwo looks back on the journey of five clinical trials, a gut microbiome database approaching 80,000 patients, hundreds of commercial customers, payers, providers, employers and shares lessons learned, challenges confronted, and the road ahead for the worlds largest gut-microbiome human discovery platform.
This event is supported by IAFNS Gut Microbiome Committee.